Research Topics
Genomes and Genes | Eric HollanderSummaryAffiliation: Montefiore Medical Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disordersEric Hollander
Autism and Obsessive Compulsive Spectrum Program, Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, New York, USA
Am J Psychiatry 169:292-9. 2012..The effects of fluoxetine and placebo on repetitive behaviors and global severity were compared in adults with autism spectrum disorders (ASDs)...
Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disordersEric Hollander
Department of Psychiatry, Montefiore Medical Center University Hospital for Albert Einstein College of Medicine, Child Psychiatry Annex, Bronx, NY 10467 2490, USA
Neuropsychopharmacology 35:990-8. 2010..This study suggests the efficacy of divalproex for the treatment of irritability in children and adolescents with ASD. Larger sample follow-up studies are warranted...
Cross-cutting issues and future directions for the OCD spectrumEric Hollander
Department Psychiatry, Child Psychiatry Annex, Montefiore Medical Center, University Hospital of Albert Einstein College of Medicine, Bronx, NY 10467 2490, United States
Psychiatry Res 170:3-6. 2009....
Neurological considerations: autism and Parkinson's diseaseEric Hollander
Department of Psychiatry, Montefiore Medical Center, University Hospital of Albert Einstein College of Medicine, Bronx, NY 10467 2490, United States
Psychiatry Res 170:43-51. 2009..The current review focuses on the phenomenology, comorbidity, course of illness, family history, brain circuitry, and treatment of autism and PD, as they relate to OCD and OC spectrum disturbances...
Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapseEric Hollander
Montefiore Medical Center University Hospital for Albert Einstein College of Medicine Child Psychiatry Annex, 111 E 210th St, Bronx, NY 10467 2490, USA
J Clin Psychiatry 71:784-92. 2010....
Positron emission tomography imaging of risperidone augmentation in serotonin reuptake inhibitor-refractory patientsMonte S Buchsbaum
Mount Sinai School of Medicine, New York, NY 10029, USA
Neuropsychobiology 53:157-68. 2006..Our results are consistent with a frontostriatal circuit change related to both dopaminergic and serotonergic systems and with the presence of psychopharmacological subtypes within OCD...
FDG-PET study in pathological gamblers. 1. Lithium increases orbitofrontal, dorsolateral and cingulate metabolismEric Hollander
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
Neuropsychobiology 58:37-47. 2008..Although mood stabilizers and serotonin reuptake inhibitors have shown some efficacy in the treatment of this condition, there is little known about how these pharmacological interventions work...
Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gamblingJon E Grant
Department of Psychiatry, University of Minnesota Medical School, 2450 Riverside Avenue, Minneapolis, MN 55454, USA
Am J Psychiatry 163:303-12. 2006..The authors examined the efficacy and tolerability of the opioid antagonist nalmefene in the treatment of adults with pathological gambling...
Volumetric analysis and three-dimensional glucose metabolic mapping of the striatum and thalamus in patients with autism spectrum disordersM Mehmet Haznedar
Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1505, New York, NY 10029, USA
Am J Psychiatry 163:1252-63. 2006..The authors used imaging studies to map volumetric and metabolic differences within the entire dorsoventral extent of the striatum and thalamus...
Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?Eric Hollander
Compulsive, Impulsive, and Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
Am J Psychiatry 162:137-45. 2005..To the authors' knowledge, this is the first placebo-controlled treatment study in pathological gamblers with bipolar spectrum disorders; it compares sustained-release lithium carbonate to placebo...
Escitalopram in the treatment of impulsive-compulsive internet usage disorder: an open-label trial followed by a double-blind discontinuation phaseBernardo Dell'Osso
Department of Psychiatry, Compulsive and Impulsive Disorders Program, Mount Sinai School of Medicine, New York, NY 10029, USA
J Clin Psychiatry 69:452-6. 2008..To assess the safety and efficacy of escitalopram in IC-IUD, we conducted a 10-week, open-label trial followed by a 9-week, double-blind, placebo-controlled discontinuation phase...
Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorderEric Hollander
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
Int J Neuropsychopharmacol 9:209-13. 2006..616). This study provides preliminary support for the use of divalproex in treating repetitive behaviours in ASD. Further research is needed to evaluate the specificity and mechanism of action of these findings...
Basal Ganglia activity in pathological gambling: a fluorodeoxyglucose-positron emission tomography studyStefano Pallanti
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA
Neuropsychobiology 62:132-8. 2010..We extended our studies to include functional alterations of the striatum and thalamus in a cohort of patients with PG before and after treatment with lithium...
Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorderEric Hollander
Department of Psychiatry, Mount Sinai School of Medicine, 1 Gustave L Levy Place, Box 1230, New York, NY 10029 6574, USA
Am J Psychiatry 162:621-4. 2005....
Oxytocin increases retention of social cognition in autismEric Hollander
Mount Sinai School of Medicine, New York, New York, USA
Biol Psychiatry 61:498-503. 2007..This study explored the effect of intravenous oxytocin administration on the retention of social information in autism...
Dissociation and posttraumatic stress 1 year after the World Trade Center disaster: follow-up of a longitudinal surveyDaphne Simeon
Mount Sinai School of Medicine, Department of Psychiatry, New York, NY 10029, USA
J Clin Psychiatry 66:231-7. 2005..We conducted a 1-year follow-up of an original mail survey of early reactions to the World Trade Center disaster...
Factor analysis of repetitive behaviors in Autism as measured by the Y-BOCSEvdokia Anagnostou
Dept of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA
J Neuropsychiatry Clin Neurosci 23:332-9. 2011..These findings are another step in the effort to identify genetically and biologically distinct groups within this population...
Mutation analysis of the NSD1 gene in patients with autism spectrum disorders and macrocephalyJoseph D Buxbaum
Laboratory of Molecular Neuropsychiatry, Mount Sinai School of Medicine, New York, USA
BMC Med Genet 8:68. 2007..Sotos syndrome has been described in a number of patients with autism spectrum disorders, suggesting that NSD1 could be involved in other cases of autism and macrocephaly...
A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorderEric Hollander
Seaver and NY Autism Center of Excellence, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1230, New York, New York 10029, USA
J Child Adolesc Psychopharmacol 16:541-8. 2006..Additional studies are needed to determine the efficacy and safety of olanzapine in the treatment of children with PDD...
Ondansetron augmentation in treatment-resistant obsessive-compulsive disorder: a preliminary, single-blind, prospective studyStefano Pallanti
Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029, USA
CNS Drugs 23:1047-55. 2009..Trial registration number (ClinicalTrials.gov): NCT00796497...
Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled studyEric Hollander
Department of Psychiatry, The Mount Sinai School of Medicine, New York, NY, USA
Int J Neuropsychopharmacol 6:397-401. 2003..Risperidone may be an effective and well-tolerated augmentation strategy in treatment-resistant OCD subjects, but larger sample size studies are required to demonstrate this...
Relationship between whole blood serotonin and repetitive behaviors in autismAlexander Kolevzon
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
Psychiatry Res 175:274-6. 2010..No significant associations were found between serotonin level and the primary behavioral outcome measures. However, a significant inverse relationship between serotonin level and self-injury was demonstrated...
Association analysis of the NrCAM gene in autism and in subsets of families with severe obsessive-compulsive or self-stimulatory behaviorsTakeshi Sakurai
Departments of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029, USA
Psychiatr Genet 16:251-7. 2006....
Predicting response to opiate antagonists and placebo in the treatment of pathological gamblingJon E Grant
Department of Psychiatry, University of Minnesota School of Medicine, 2450 Riverside Avenue, Minneapolis, MN 55454, USA
Psychopharmacology (Berl) 200:521-7. 2008..No studies have systematically examined predictors of medication treatment outcome in PG. Understanding clinical variables related to treatment outcome should help generate treatment algorithms for PG...
An open-label trial of divalproex extended-release in the treatment of borderline personality disorderDaphne Simeon
Department of Psychiatry, The Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029, USA
CNS Spectr 12:439-43. 2007..Divalproex extended-release (ER) is used widely in clinical practice, which leads to the question of its efficacy and tolerability in treating BPD...
A preliminary study of cortisol and norepinephrine reactivity to psychosocial stress in borderline personality disorder with high and low dissociationDaphne Simeon
Department of Psychiatry, Mount Sinai School of Medicine, Psychiatry Box 1230, One Gustave L Levy Place, New York, NY 10029, USA
Psychiatry Res 149:177-84. 2007..In conclusion, despite its small sample size this pilot study suggests that dissociative symptomatology may be a marker of heightened biological vulnerability to stress in BPD, and merits further study...
Striatal volume on magnetic resonance imaging and repetitive behaviors in autismEric Hollander
Department of Psychiatry, Mount Sinai School of Medicine, Annenberg Bldg, 1 Gustave L Levy Place, New York, NY 10029, USA
Biol Psychiatry 58:226-32. 2005....
Epidemiologic and clinical updates on impulse control disorders: a critical reviewBernardo Dell'Osso
Compulsive, Impulsive and Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1230, New York, NY 10029, USA
Eur Arch Psychiatry Clin Neurosci 256:464-75. 2006..Particular attention is paid to the relationship between ICDs and obsessive-compulsive disorder (OCD). Finally, current pharmacological options for treating ICDs are presented and discussed...
Autism-related routines and rituals associated with a mitochondrial aspartate/glutamate carrier SLC25A12 polymorphismJeremy M Silverman
Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029, USA
Am J Med Genet B Neuropsychiatr Genet 147:408-10. 2008..No other significant differences were observed. The rs2056202 polymorphism may be associated with levels of routines and rituals in autism and related disorders...
Pharmacological treatments of pathological gamblingEric Hollander
Department of Psychiatry, Compulsive, Impulsive and Anxiety Disorders Program, Mount Sinai School of Medicine, Box 1230, One Gustave L Levy Place, New York, NY, USA
J Gambl Stud 21:99-110. 2005..This review focuses on recent research examining the treatment of pathological gambling and highlights methodological challenges for future studies...
A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autismEric Hollander
Seaver and New York Autism Center of Excellence, New York, NY 10029, USA
Neuropsychopharmacology 30:582-9. 2005..Limitations include small sample size and the crossover design of the study. Further replication and long-term maintenance trials are needed...
The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity studySuck Won Kim
Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN 55454, USA
Psychiatry Res 166:76-84. 2009..The correlations between the G-SAS and the PG-YBOCS and Clinical Global Impression rating were excellent. Findings suggest that the G-SAS is reliable and valid in assessing changes in symptoms during a drug treatment study...
Oxytocin can hinder trust and cooperation in borderline personality disorderJennifer Bartz
Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1230, New York, NY 10029, USA
Soc Cogn Affect Neurosci 6:556-63. 2011..Although popularly dubbed the 'hormone of love', these data suggest a more circumspect answer to the question of who will benefit from OXT...
Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS)Stefano Pallanti
Mount Sinai School of Medicine, New York, NY 10029, USA
J Gambl Stud 21:431-43. 2005..PG-YBOCS thus appears to be a reliable and valid measure of pathological gambling severity, and can be regarded as an important tool for clinicians and researchers treating pathological gamblers...
Family-based association study of TPH1 and TPH2 polymorphisms in autismNicolas Ramoz
Laboratory of Molecular Neuropsychiatry, Mount Sinai School of Medicine, New York, New York 10029, USA
Am J Med Genet B Neuropsychiatr Genet 141:861-7. 2006..Thus, it appears unlikely that the TPH1 and TPH2 genes play a significant role in the susceptibility to autism or to autism endophenotypes including sOCB and SSB...
Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled studyStacey Wasserman
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
Int Clin Psychopharmacol 21:363-7. 2006..These findings suggest that levetiracetam does not improve behavioral disturbances of autism, but are limited by the small sample size and lack of stratification of the autistic sample at baseline...
Oxytocin and experimental therapeutics in autism spectrum disordersJennifer A Bartz
Mount Sinai School of Medicine, New York, NY, USA
Prog Brain Res 170:451-62. 2008..Finally, we conclude with a discussion of directions for future research...
A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorderEric Hollander
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
J Clin Psychiatry 64:640-7. 2003....
Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical reviewGerald Nestadt
Department of Psychiatry, Compulsive, Impulsive and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, NY 10029, USA
J Clin Psychiatry 67:600-10. 2006..Double-blind, placebo-controlled studies are, however, needed to confirm the positive findings reported by several studies with venlafaxine...
Serotonin function in pathological gambling: blunted growth hormone response to sumatriptanStefano Pallanti
Department of Psychiatry, The Mount Sinai School of Medicine, 1 Gustave Levy Place, New York, NY 10029, USA
J Psychopharmacol 24:1802-9. 2010..These results, together with those obtained in our previous serotoninergic challenge study, document the presence of a serotonergic dysfunction in pathological gamblers similar to that reported in alcoholics...
An open-label trial of venlafaxine in body dysmorphic disorderAndrea Allen
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA
CNS Spectr 13:138-44. 2008..This open-label trial examines venlafaxine's efficacy in BDD and is the first known study of this serotonin-norepinephrine reuptake inhibitor in BDD...
Fronto-thalamo-striatal gray and white matter volumes and anisotropy of their connections in bipolar spectrum illnessesM Mehmet Haznedar
Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029 6574, USA
Biol Psychiatry 57:733-42. 2005....
Impulsive-compulsive sexual behaviorThomas M Mick
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
CNS Spectr 11:944-55. 2006..The data regarding this disorder and its overlap with chemical addiction is limited. If the two disorders are to be grouped together, further data are needed...
A double-blind, placebo-controlled trial of topiramate for pathological gamblingHeather A Berlin
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
World J Biol Psychiatry 14:121-8. 2013..Earlier studies suggested that topiramate may be effective in treating some impulse control disorders. We conducted the first randomized, controlled trial of topiramate in PG...
Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trialEvdokia Anagnostou
Mount Sinai School of Medicine, One Gustave L, Levy Place, New York, NY 10029 6574, USA
Mol Autism 3:16. 2012..abstract:..
Psychopharmacologic interventions for repetitive behaviors in autism spectrum disordersLatha Soorya
Department of Psychiatry, Seaver and New York Autism Center of Excellence, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1230, New York, NY 10029, USA
Child Adolesc Psychiatr Clin N Am 17:753-71, viii. 2008..To date, data are mixed for interventions commonly prescribed in clinical practice and suggest several areas of investigation in advancing research on the medication management of repetitive behaviors...
Extended-release fluvoxamine and improvements in quality of life in patients with obsessive-compulsive disorderLorrin M Koran
Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, CA 94305, USA
Compr Psychiatry 51:373-9. 2010..We also hypothesized that greater OCD symptom improvement in the first 12 weeks of treatment would be associated with greater HRQOL improvement after 52 weeks of treatment...
Relationship of personality to dissociation and childhood trauma in borderline personality disorderDaphne Simeon
Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA
CNS Spectr 8:755-62. 2003..The purpose of this study was to investigate the relationship between dissociation and childhood trauma in BPD and to explore the relationships of dissociation and trauma to various personality features of BPD...
The neuroscience of affiliation: forging links between basic and clinical research on neuropeptides and social behaviorJennifer A Bartz
Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1230, New York, NY 10029, USA
Horm Behav 50:518-28. 2006..Finally, unresolved issues and directions for future research are discussed...
Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depressionMadhukar H Trivedi
Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, TX 75235, USA
J Clin Psychiatry 69:246-58. 2008..This article reviews research on the current understanding and management of residual symptoms, i.e., subthreshold depressive symptoms present after recovery from a major depressive episode...
Bipolar disorder and comorbid attention deficit hyperactivity disorder. A distinct clinical phenotype? Clinical characteristics and temperamental traitsSilvia Bernardi
Department of Psychiatry, Mount Sinai School of Medicine, New York 10029, USA
World J Biol Psychiatry 11:656-66. 2010..We further hypothesize that maladaptive temperament will be associated with the severity of both illnesses...
Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled studyJon E Grant
Department of Psychiatry, University of Minnesota Medical School, 2450 Riverside Avenue, Minneapolis, MN 55454, USA
Br J Psychiatry 197:330-1. 2010..These findings suggest that medication dosing may be an important consideration in achieving symptom control...
Increased repetitive behaviours and prolactin responsivity to oral m-chlorophenylpiperazine in adults with autism spectrum disordersSherie Novotny
Department of Psychiatry, Seaver Autism Research Center at the Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY, 10029, USA
Int J Neuropsychopharmacol 7:249-54. 2004....
Topiramate plus paroxetine in treatment-resistant obsessive-compulsive disorderEric Hollander
Department of Psychiatry, Compulsive, Impulsive and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, New York 10029, USA
Int Clin Psychopharmacol 21:189-91. 2006..Our case suggests that topiramate might be beneficial in augmentation with selective serotonin reuptake inhibitors in patients with treatment-resistant OCD, although further investigations are warranted to confirm our findings...
WCA recommendations for the long-term treatment of generalized anxiety disorderChrister Allgulander
Department of Psychiatry, Harvard University School of Medicine, Boston, Massachusetts, USA
CNS Spectr 8:53-61. 2003..Treatment gains after a 12-week course of CBT may be maintained for up to 1 year. Currently, no guidelines exist for the long-term treatment of GAD...
Nefazodone treatment of pathological gambling: a prospective open-label controlled trialStefano Pallanti
Department of Psychiatry, Mount Sinai School of Medicine, New York, N.Y, USA
J Clin Psychiatry 63:1034-9. 2002..Side effects (dry mouth and sedation) of moderate severity occurred in 4 subjects. CONCLUSION: These preliminary results suggest that nefazodone may be effective in reducing symptoms of pathological gambling and is well tolerated...
Lack of evidence for association of the serotonin transporter gene SLC6A4 with autismNicolas Ramoz
Laboratory of Molecular Neuropsychiatry, Department of Psychiatry, Seaver Autism Research Center, Mount Sinai School of Medicine, New York, New York 10029, USA
Biol Psychiatry 60:186-91. 2006..Specific variants of the 5-HTT gene, SLC6A4, especially the insertion-deletion 5-HTTLPR promoter locus, have been found to modulate its expression and transporter function...
Comprehensive treatment of three patients with comorbid OCPD and ADHDStephen C Josephson
Cornell University Medical School, New York, NY, USA
CNS Spectr 12:338-42. 2007..Significant symptom reduction was observed as a result of this combined intervention...
Targeted treatments for symptom domains in child and adolescent autismEric Hollander
Seaver and New York Autism Center of Excellence, Mount Sinai School of Medicine, New York, NY 10029, USA
Lancet 362:732-4. 2003..Other symptom domains within autism and effects on development need to be evaluated in adequately designed clinical trials. Future strategies include extending treatment to children as young as the preschool years...
In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autismSilvia Bernardi
Seaver Autism Center for Research and Treatment, Mount Sinai School of Medicine, New York, NY 10029 6574, USA
Brain Res 1380:198-205. 2011..This study provides evidence of abnormalities in neurotransmission related to networks subserving executive control and alerting of attention, functions which have been previously implicated in ASD pathogenesis...
Venlafaxine in treatment-resistant obsessive-compulsive disorderEric Hollander
Department of Psychiatry, Compulsive, Impulsive, and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, NY 10029, USA
J Clin Psychiatry 64:546-50. 2003..Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that might be effective in the treatment of OCD, even among those who have failed previous SSRI trials...
Experimental therapeutics for refractory obsessive-compulsive disorder: translational approaches and new somatic developmentsHeather A Berlin
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA
Mt Sinai J Med 75:174-203. 2008....
The impact of comorbidity on the management of pathological gamblingEric Hollander
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
CNS Spectr 10:619-21. 2005..The identification of specific subtypes among patients with pathological gambling may be relevant to the choice of pharmacologic treatment...
Imaging monetary reward in pathological gamblersEric Hollander
Department of Psychiatry, Box 1230, Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029, USA
World J Biol Psychiatry 6:113-20. 2005....
The 5-HT(2A) receptor and serotonin transporter in Asperger's disorder: A PET study with [¹¹C]MDL 100907 and [¹¹C]DASBRagy R Girgis
Department of Psychiatry, Columbia University and New York State Psychiatric Institute, New York, NY 10032, USA
Psychiatry Res 194:230-4. 2011..This study failed to find significant alterations in binding parameters of 5-HT(2A) receptors and serotonin transporters in adult subjects with Asperger's disorder...
Beyond refractory obsessions and anxiety states: toward remissionEric Hollander
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
J Clin Psychiatry 65:3-5. 2004..These and other issues should be discussed at future meetings of the IOCDC and influence how we conceptualize the disorder and design future treatment trials...
Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetineEric Hollander
Department of Psychiatry, Box 1230, Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029 6574, USA
J Clin Psychiatry 64:1113-21. 2003..This study evaluated the acute safety and efficacy and long-term efficacy, safety, and impact on relapse prevention of paroxetine in obsessive-compulsive disorder...
Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerabilityAlexander Kolevzon
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA
J Clin Psychiatry 67:407-14. 2006..This article reviews the available data on the efficacy and tolerability of SSRIs in individuals with autism spectrum disorders. Objectives for future research in this area will also be suggested...
Obsessive-compulsive disorder spectrum as a scientific "metaphor"Stefano Pallanti
Strategic Center of Excellence of Psychiatry, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA
CNS Spectr 13:6-15. 2008..By increasing research in this field, the OCD spectrum may evolve from a fragmented level of conceptualization as a "metaphor" to one that is more comprehensive and structured...
Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorderAndrea Allen
Compulsive, Impulsive and Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, Box 1230, New York, NY 10029, USA
Expert Opin Pharmacother 6:2727-40. 2005..This reflects the poor affinity of this compound for adrenergic, muscarinic, cholinergic or histaminergic receptors...
Refractory obsessive-compulsive disorder: state-of-the-art treatmentEric Hollander
Department of Psychiatry, Compulsive, Impulsive, and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, NY 10029, USA
J Clin Psychiatry 63:20-9. 2002..The authors synthesize state-of-the-art treatment and give practical advice for clinicians...
Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disordersEric Hollander
Department of Psychiatry, Seaver Autism Research Center, Mount Sinai School of Medicine, New York, NY 10029, USA
Neuropsychopharmacology 28:193-8. 2003..Repetitive behavior in autism spectrum disorders may be related to abnormalities in the oxytocin system, and may be partially ameliorated by synthetic oxytocin infusion...
Impact of recent findings on study design of future autism clinical trialsEric Hollander
Department of Psychiatry, Mount Sinai School of Medicine, New York City, New York 10029 6574, USA
CNS Spectr 9:49-56. 2004..The Internet System for Assessing Autistic Children system for managing multicenter clinical trials in autism and statistical issues in autism research are also described...
Autism and oxytocin: new developments in translational approaches to therapeuticsJoshua J Green
Montefiore Medical Center, University Hospital of Albert Einstein College of Medicine, Bronx, New York 10467, USA
Neurotherapeutics 7:250-7. 2010..We also discuss current research limitations, review recent preliminary findings from studies involving oxytocin in autism spectrum disorder patient populations, and point to possible directions for future research...
Diagnosis and treatment of pathologic gamblingErica D Sood
Department of Psychiatry, The Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1230, New York, NY 10029, USA
Curr Psychiatry Rep 5:9-15. 2003..This review focuses on recent research examining the neurobiology and treatment of PG...
Comorbidity in compulsive hoarding: a case reportAlicia Kaplan
Department of Psychiatry, Mount Sinai School of Medicine, New York City, New York 10029-6574, USA
CNS Spectr 9:71-3. 2004..Augmentation with stimulants may provide benefits in aspects of hoarding such as procrastination, especially in patients with comorbid attention-deficit hyperactivity disorder...
A review of pharmacologic treatments for obsessive-compulsive disorderAlicia Kaplan
Department of Psychiatry, Mount Sinai Scjhool of Medicine, New York, New York 10029, USA
Psychiatr Serv 54:1111-8. 2003..In this article the authors review studies of pharmacologic treatments...
Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disordersEric Hollander
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
Neuropsychopharmacology 28:1186-97. 2003....
Brain stimulation techniques in the treatment of obsessive-compulsive disorder: current and future directionsBernardo Dell'Osso
Department of Psychiatry, Compulsive, Impulsive and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, NY 10029, USA
CNS Spectr 10:966-79, 983. 2005..Nevertheless, promising findings regarding efficacy, tolerability, and non-invasiveness and/or reversibility of these techniques have increased interest in investigating their use in treatment-resistant OCD...
Obsessive-compulsive disorder and obsessive-compulsive spectrum disorders: diagnostic and dimensional issuesEric Hollander
Department of Psychiatry, The Mount Sinai School of Medicine, New York, NY, USA
CNS Spectr 12:5-13. 2007..Advantages and disadvantages of establishing OCSDs and its implications for diagnosis, treatment, and research are discussed...
Obsessive compulsive disorder comorbidity in DBAStefano Pallanti
Department of Psychiatry, The Mount Sinai School of Medicine, New York, NY, USA
Clin Pract Epidemiol Ment Health 4:6. 2008....
Diagnosis and treatment of body dysmorphic disorder in adolescentsSallie Jo Hadley
Mount Sinai Medical Center, Department of Psychiatry, Box 1230, New York, NY 10029, USA
Curr Psychiatry Rep 4:108-13. 2002....
Symptom domains in autism and related conditions: evidence for familialityJeremy M Silverman
Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029, USA
Am J Med Genet 114:64-73. 2002..Making distinctions among families by the severity of these features may be useful for identifying more genetically homogeneous subgroups in studies targeted at genes for specific autism-related symptom domains...
Regional glucose metabolism within cortical Brodmann areas in healthy individuals and autistic patientsErin A Hazlett
Department of Psychiatry, Mount Sinai School of Medicine, New York, N Y, USA
Neuropsychobiology 49:115-25. 2004..Patients failed to show these patterns. Autism patients have dysfunction in some but not all of the key brain regions subserving verbal memory performance, and other regions may be recruited for task performance...
